TrialHuman vaccines & immunotherapeutics2023

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.

Xiaoyuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.